Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Letter July 11 2025
Ibrutinib increases miR-181a/b in leukemic cells from patients with chronic lymphocytic leukemia
Letter July 11 2025
Genetic variation at PPM1H predicts mobilization efficiency in stem cell donors
Research Article July 11 2025
Hybridization Capture Long-Read Sequencing & De Novo Assembly of Homologous Haplotypes: A Comprehensive Hemophilia Test
Letter July 11 2025
Platelet glycosylation in myelodysplastic syndromes correlates with disease severity
Letter July 11 2025
Bing-Neel Syndrome - A Case Series of 46 Patients from the United Kingdom
Research Article July 11 2025
Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia
Research Article July 11 2025
Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation
Research Article July 11 2025
Sequential BCMA CAR-T Cell Therapy in Refractory Multiple Myeloma
Letter July 3 2025
PROM1/CD133 MARKS A PROLIFERATIVE STEM CELL LIKE POPULATION OF BLASTS IN KMT2A REARRANGED INFANT ALL
Research Article July 3 2025
Sex and genotype specificities of microvasculature and muscle remodeling in sub-Saharan sickle cell trait and disease
Research Article July 3 2025
Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice
Research Article July 3 2025
Age-Adjusted Dosing of Fludarabine for Lymphodepletion in CAR T-cell Therapy: A Clinical Trial Simulation Study
Research Article July 3 2025
Association of Sleep Study Outcomes and Healthcare Utilization in Children with Sickle Cell Disease, a Multicenter Study
Letter July 3 2025
Incomplete Harms Reporting in Systematic Reviews of Direct Oral Factor Xa Inhibitors
Research Article July 2 2025
Mitochondrial iron transport via MFRN1 is required for erythroid cell cycle progression
Research Article July 2 2025
Symptoms, unmet needs, and quality of life in Erdheim-Chester disease: A longitudinal registry-based analysis
Letter July 2 2025
Long term outcomes of genome edited 'universal' CAR19 T-cells for relapsed/refractory B-ALL at a single pediatric centre
Letter July 2 2025
Asciminib for relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Research Article July 2 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma
Research Article July 1 2025
Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific Antibodies
Research Article July 1 2025
Prospective Cohort Study of eDiary Acute Pain Assessments in Sickle Cell Disease During Third Trimester and Postpartum
Research Article July 1 2025
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia
Letter July 1 2025
Dose-Reduced Apixaban for Secondary Prophylaxis in Severely Obese Patients: A Single Center Analysis
Research Article July 1 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC
Research Article July 1 2025
Comparative Infection Risk in CAR T vs Bispecific Antibodies in B cell Lymphoma: A Systematic Review and Meta-Analysis
Letter July 1 2025
R-CHOP and R-cytarabine for transplant-ineligible MCL
Review Article July 1 2025
Therapeutic Innovations in Hemophilia: The Essential Role of a Positive Reinvestment Cycle
Research Article July 1 2025
Effect of age on ISTH-BAT scores and Low VWF diagnosis in the Zimmerman Program
Research Article June 26 2025
Efficacy and Safety of BCMA Nanobody CAR-T Cell Therapy in Relapsed or Refractory Plasma Cell Myeloma
Research Article June 26 2025
Prognostic Impact of Focal Lesion Location and Persistence in Multiple Myeloma: Insights from Serial PET/DWI Imaging
Research Article June 26 2025
From CyBorD to Dara-CyBorD: ASCT Utilization Trends in AL Amyloidosis, A 15-Year Analysis
Letter June 25 2025
Moving Beyond The Eyeball Test for Fitness Assessment in AML
Letter June 25 2025
Blood-derived Cell-Free DNA is a Superior Biomarker for Non-Invasive DNA Methylation Profiling in Multiple Myeloma
Letter June 25 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy
Review Article June 25 2025
Efficacy and Safety of Thrombolysis for Pediatric Venous Thromboembolism: A Systematic Review and Meta-analysis
Research Article June 24 2025
Evaluation of In vivo CAR Transgene Levels in Tisagenlecleucel-Treated Patients with Relapsed/Refractory B-ALL and DLBCL
Research Article June 24 2025
In vivo tracking of transfused platelets by next-generation sequencing of mitochondrial DNA
Research Article June 24 2025
A prospective clinical trial of GVHD prophylaxis with Post-Transplant Cyclophosphamide and Abatacept
Review Article June 24 2025
Upfront Alternative Donor HCT in Severe Aplastic Anemia: Gaps and Opportunities to Translate Evidence into Practice
Research Article June 24 2025
The TET protein family interactor PROSER1 sustains hematopoietic stem cell function
Research Article June 24 2025
Multi-population GWAS for venous thromboembolism identifies novel loci followed by experimental validation in zebrafish
Research Article June 24 2025
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry
Research Article June 24 2025
A Mixed Methods Study to Understand the Role of Knowledge in Transition among Youth with Sickle Cell Disease
Research Article June 24 2025
Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease
Research Article June 24 2025
Long-term outcomes of patients with refractory cytopenia of childhood under observation only
Letter June 24 2025
Racial Disparities in the Management of Deep Vein Thrombosis from a Nationwide Hospitalization Study
Research Article June 24 2025
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse
Letter June 20 2025
Serum TARC: a biomarker for early detection or exclusion of relapse in classic Hodgkin Lymphoma
Research Article June 20 2025
Allogeneic haematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study
Research Article June 20 2025
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a Phase I trial.
Page 1 of 3

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals